-
1
-
-
0034183543
-
The role of bone biopsy in the diagnosis of renal osteodystrophy
-
Sprague SM: The role of bone biopsy in the diagnosis of renal osteodystrophy. Seminars in Dialysis 13:152-155, 2000
-
(2000)
Seminars in Dialysis
, vol.13
, pp. 152-155
-
-
Sprague, S.M.1
-
2
-
-
0017288983
-
Bone histology in incipient and advanced renal failure
-
Malluche HH, Ritz E, Lange HP: Bone histology in incipient and advanced renal failure. Kidney Int 9:355-362, 1976
-
(1976)
Kidney Int
, vol.9
, pp. 355-362
-
-
Malluche, H.H.1
Ritz, E.2
Lange, H.P.3
-
3
-
-
0036176161
-
Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification
-
Levey A, Coresh J, Bolton K: Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39:S46-S76, 2002 (suppl 1)
-
(2002)
Am J Kidney Dis
, vol.39
, Issue.SUPPL. 1
-
-
Levey, A.1
Coresh, J.2
Bolton, K.3
-
4
-
-
0015514781
-
On the pathogenesis of the uremic state. An exposition of the trade off hypothesis
-
Bricker NS: On the pathogenesis of the uremic state. An exposition of the trade off hypothesis. N Eng J Med 286:1093, 1972
-
(1972)
N Eng J Med
, vol.286
, pp. 1093
-
-
Bricker, N.S.1
-
6
-
-
0027217909
-
Decreased 1,25 dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients
-
Fukuda N, Tanaka H, Tominaga, et al: Decreased 1,25 dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443, 1993
-
(1993)
J Clin Invest
, vol.92
, pp. 1436-1443
-
-
Fukuda, N.1
Tanaka, H.2
Tominaga3
-
7
-
-
0031042732
-
Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
-
Gogusev J, Duchambon P, Hory B, et al: Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328-336, 1997
-
(1997)
Kidney Int
, vol.51
, pp. 328-336
-
-
Gogusev, J.1
Duchambon, P.2
Hory, B.3
-
8
-
-
0029052122
-
Mechanisms of disease: Renal osteodystrophy
-
Hruska K, Teitelbaum S: Mechanisms of disease: Renal osteodystrophy. N Eng J Med 333:1666-1674, 1995
-
(1995)
N Eng J Med
, vol.333
, pp. 1666-1674
-
-
Hruska, K.1
Teitelbaum, S.2
-
9
-
-
0027178439
-
The spectrum of bone disease in end-stage renal failure: An evolving disorder
-
Sherrard DJ, Hercz G, Pei Y, et al: The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 43:436-442, 1993
-
(1993)
Kidney Int
, vol.43
, pp. 436-442
-
-
Sherrard, D.J.1
Hercz, G.2
Pei, Y.3
-
10
-
-
0029036314
-
Bone disease in predialysis, hemodialysis and CAPD patients: Evidence of a better bone response to PTH
-
Torres A, Lorenzo V, Hernandez D, et al: Bone disease in predialysis, hemodialysis and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47:1434-1442, 1995
-
(1995)
Kidney Int
, vol.47
, pp. 1434-1442
-
-
Torres, A.1
Lorenzo, V.2
Hernandez, D.3
-
11
-
-
0034816224
-
Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases
-
Fukagawa M, Kazama J, Shigematsu T: Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases. Am J Kidney Dis 38: S152-S155, 2001 (suppl 1)
-
(2001)
Am J Kidney Dis
, vol.38
, Issue.SUPPL. 1
-
-
Fukagawa, M.1
Kazama, J.2
Shigematsu, T.3
-
12
-
-
0028788558
-
Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
-
Wang, Herz G, Sherrard D, et al: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836-844, 1995
-
(1995)
Am J Kidney Dis
, vol.26
, pp. 836-844
-
-
Wang1
Herz, G.2
Sherrard, D.3
-
13
-
-
0018869739
-
Renal osteodystrophy
-
Coburn J: Renal osteodystrophy. Kidney Int 17:677-693, 1980
-
(1980)
Kidney Int
, vol.17
, pp. 677-693
-
-
Coburn, J.1
-
14
-
-
0021989102
-
Who gets renal bone disease before beginning dialysis?
-
Cundy T, Hand DJ, Oliver DO, et al: Who gets renal bone disease before beginning dialysis? British Med J 290:271-275, 1985
-
(1985)
British Med J
, vol.290
, pp. 271-275
-
-
Cundy, T.1
Hand, D.J.2
Oliver, D.O.3
-
15
-
-
0029017054
-
Effect of administering calcium carbonate to treat secondary hyperparathyroidism in non-dialyzed patients with chronic renal failure
-
Tsukamoto Y, Moriya R, Nagaba Y, et al: Effect of administering calcium carbonate to treat secondary hyperparathyroidism in non-dialyzed patients with chronic renal failure. Am J Kidney Dis 25:879-886, 1995
-
(1995)
Am J Kidney Dis
, vol.25
, pp. 879-886
-
-
Tsukamoto, Y.1
Moriya, R.2
Nagaba, Y.3
-
16
-
-
0032828179
-
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
-
Rix M, Andreassen H, Eskildsen P, et al: Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084-1093, 1999
-
(1999)
Kidney Int
, vol.56
, pp. 1084-1093
-
-
Rix, M.1
Andreassen, H.2
Eskildsen, P.3
-
17
-
-
0029118191
-
Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
-
Qi A, Monier-Faugere M, Geng Z, et al: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622-631, 1995
-
(1995)
Am J Kidney Dis
, vol.26
, pp. 622-631
-
-
Qi, A.1
Monier-Faugere, M.2
Geng, Z.3
-
18
-
-
0026652885
-
Intact parathyroid hormone overestimates the presence and severity of parathyroid mediated osseous abnormalities in uremia
-
Quarles L, Labaugh B, Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid mediated osseous abnormalities in uremia. J Clin Endocrin Metab 75:145-150, 1992
-
(1992)
J Clin Endocrin Metab
, vol.75
, pp. 145-150
-
-
Quarles, L.1
Labaugh, B.2
Murphy, G.3
-
19
-
-
0028391363
-
The role of bone biopsy in the management of patients with renal osteodystrophy
-
Malluche H, Faugere M: The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Neph 4:1631-1643. 1994
-
(1994)
J Am Soc Neph
, vol.4
, pp. 1631-1643
-
-
Malluche, H.1
Faugere, M.2
-
20
-
-
0029921693
-
Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients
-
Urena P, Hruby M, Ferreira A, et al: Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7:506-512, 1996
-
(1996)
J Am Soc Nephrol
, vol.7
, pp. 506-512
-
-
Urena, P.1
Hruby, M.2
Ferreira, A.3
-
21
-
-
0033021783
-
Circulating biochemical markers of bone remodeling in uremic patients
-
Urena P, de Vernejoul M: Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141-2156, 1999
-
(1999)
Kidney Int
, vol.55
, pp. 2141-2156
-
-
Urena, P.1
De Vernejoul, M.2
-
22
-
-
0026731258
-
Procollagen type I C-terminal extension peptide in predialysis chronic renal failure
-
Coen G, Mazzaferro S, Ballanti P, et al: Procollagen type I C-terminal extension peptide in predialysis chronic renal failure. Am J Nephrol 12:246-251, 1992
-
(1992)
Am J Nephrol
, vol.12
, pp. 246-251
-
-
Coen, G.1
Mazzaferro, S.2
Ballanti, P.3
-
23
-
-
0028837248
-
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure
-
Hamdy N, Kanis J, Beneton M, et al: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Brit Med J 310:358-363, 1995
-
(1995)
Brit Med J
, vol.310
, pp. 358-363
-
-
Hamdy, N.1
Kanis, J.2
Beneton, M.3
-
24
-
-
0026691176
-
Bone status in different degrees of chronic renal failure
-
Bianci M, Colantonio G, Montesano A, et al: Bone status in different degrees of chronic renal failure. Bone 13:225-228, 1995
-
(1995)
Bone
, vol.13
, pp. 225-228
-
-
Bianci, M.1
Colantonio, G.2
Montesano, A.3
-
25
-
-
0029795843
-
Prevalence and risk factors for osteopenia in dialysis patients
-
Stein M, Packham D, Ebeling P, et al: Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28:515-522, 1996
-
(1996)
Am J Kidney Dis
, vol.28
, pp. 515-522
-
-
Stein, M.1
Packham, D.2
Ebeling, P.3
-
26
-
-
0027209898
-
Maintenance of bone mass in patients receiving dialytic therapy
-
Moe S, Byunghee Y, Sprague S: Maintenance of bone mass in patients receiving dialytic therapy. Am J Kidney Dis 22:300-307, 1993
-
(1993)
Am J Kidney Dis
, vol.22
, pp. 300-307
-
-
Moe, S.1
Byunghee, Y.2
Sprague, S.3
-
27
-
-
0026670524
-
Assessment of renal osteodystrophy in hemodialysis patients
-
De Vita M, Rasenas L, Bansal M, et al: Assessment of renal osteodystrophy in hemodialysis patients. Medicine 71:284-290, 1992
-
(1992)
Medicine
, vol.71
, pp. 284-290
-
-
De Vita, M.1
Rasenas, L.2
Bansal, M.3
-
28
-
-
0021261349
-
Effect of dietary phosphorus on circulating concentrations of 1,25 dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency
-
Portale A, Booth B, Halloran B, et al: Effect of dietary phosphorus on circulating concentrations of 1,25 dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580-1589, 1984
-
(1984)
J Clin Invest
, vol.73
, pp. 1580-1589
-
-
Portale, A.1
Booth, B.2
Halloran, B.3
-
29
-
-
0022414355
-
On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency
-
Llach F, Massry S: On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 61:601-606, 1985
-
(1985)
J Clin Endocrinol Metab
, vol.61
, pp. 601-606
-
-
Llach, F.1
Massry, S.2
-
30
-
-
0030814878
-
Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure
-
Kates D, Sherrard D, Andress D: Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 30(6):809-813, 1997
-
(1997)
Am J Kidney Dis
, vol.30
, Issue.6
, pp. 809-813
-
-
Kates, D.1
Sherrard, D.2
Andress, D.3
-
31
-
-
0023698497
-
Low dose calcitriol versus placebo in patients with predialysis chronic renal failure
-
Nordal K, Dahl E: Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrin Metab 67:929-936, 1988
-
(1988)
J Clin Endocrin Metab
, vol.67
, pp. 929-936
-
-
Nordal, K.1
Dahl, E.2
-
32
-
-
0024535067
-
3 administration in moderate renal failure: A prospective double-blind trial
-
3 administration in moderate renal failure: A prospective double-blind trial. Kidney Int 35:661-669, 1989
-
(1989)
Kidney Int
, vol.35
, pp. 661-669
-
-
Baker, L.1
Abrams, S.2
Roe, C.3
-
33
-
-
0034682247
-
Coronary artery calcification in young adults with end-stage renal disease undergoing dialysis
-
Goodman W, Goldin J, Kuizon B, et al: Coronary artery calcification in young adults with end-stage renal disease undergoing dialysis. N Eng J Med 342:1478-1483, 2000
-
(2000)
N Eng J Med
, vol.342
, pp. 1478-1483
-
-
Goodman, W.1
Goldin, J.2
Kuizon, B.3
-
34
-
-
0028032182
-
Calcitriol and calcium carbonate therapy in early chronic renal failure
-
Bianci M, Colantonia G, Campanini F, et al: Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant 9:1595-1599, 1994
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 1595-1599
-
-
Bianci, M.1
Colantonia, G.2
Campanini, F.3
-
35
-
-
0028940693
-
Bone mineral density evaluated by dual energy x-ray absorptiometry after one year treatment with calcitriol started in the predialysis phase of chronic renal failure
-
Przedlacki J, Manelius J, Huttenen K: Bone mineral density evaluated by dual energy x-ray absorptiometry after one year treatment with calcitriol started in the predialysis phase of chronic renal failure. Nephron 69:433-437, 1995
-
(1995)
Nephron
, vol.69
, pp. 433-437
-
-
Przedlacki, J.1
Manelius, J.2
Huttenen, K.3
|